Press "Enter" to skip to content

Human Insulin Market

Human Insulin Market by Drug type (Biologics, Biosimilars), by Delivery device (Pens, Pen Needles, Syringes), by Applications (Type 1 Diabetes, Type 2 Diabetes) and Region, Forecasts to 2026

<b>Ask for Sample/Enquiry and details report @ WMR</b>
<b><a href= “ Insulin Market by Drug type (Biolo#sample”> Insulin Market by Drug type (Biolo#sample</a></b>

WMR-Western Market Research has recently published a comprehensive and exclusive research report, which is an intelligent study covering all key segments. This research report provides breakthrough inputs and insights on market related factors like size, competition, trends, analysis, forecasts etc. The study encompasses primary and secondary data sources along with quantitative and qualitative practices thus assuring data accuracy.
The Human Insulin market was valued at USD 24.88 billion in 2018 and is predicted to grow at a CAGR of 8.1%, with forecasts for 2026 eclipsing USD 46.59 billion. The market is driven by the rising prevalence of diabetes and obesity worldwide which can be attributed to the unhealthy lifestyles. For instance, over 30 million Americans (9.4% of the population) are diagnosed with diabetes in 2015, among which 23.1 million of individuals were diagnosed and remaining 7.2 million were undiagnosed. Also, diabetes is the 7th leading reason of the deaths in worldwide. Total cost of diagnosed diabetes in US for the year 2017 was around USD 327 billion. The introduction of the safety pen needles for accurate and safe delivery is another driving factor for the global human insulin market. The human insulin market is further propelled by regulations against needle stick injuries driving the demand for safe product developments, needle anxiety, and growing awareness of blood borne pathogen transmission, which leads to consumers buying new needles, further driving sales.Insulin is a peptide hormone produced by the pancreas. It is considered to be the primary anabolic hormone which is responsible for the regulation of metabolism of carbohydrates, fats and protein by facilitating the absorption of glucose from the blood into liver, fat and skeletal muscle cells. Insulin promotes the conversion of small molecules in the blood into large molecules inside the cells. Low hormone levels in the blood promotes catabolism, which is the conversion of large molecules into smaller ones, especially of reserve body fat which may lead to numerous complications like loss of vision, unsteadiness of limbs, and obesity. A patient is prescribed different types of insulin based on many factors including their response to insulin, patients diet, alcohol intake and exercise. However, risk of skin infections at the catheter site, diabetic ketoacidosis, extremely high costs of drug and device and the hassle of checking blood glucose times per day may cause the consumer to opt out of insulin treatment which is expected to hamper the market. The insulin market is highly monopolistic with over 99% of the market captured by 3 companies which will restrain new entry into the market.

The global Human Insulin market has been segmented on the basis of product type, device type, and application. The research takes a closer look at prominent driving factors responsible for the 8.1% CAGR. The study also analyses the market share of each region, company and product. The report also presents constraints, opportunities, threats, challenges and Investment opportunities prevailing in the market.Sanofi (France), Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Julphar (U.A.E.), Ypsomed AG (Switzerland), Becton, Dickinson and Company (U.S.), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland), and Biodel Inc. (U.S.) are dominating players in the market and are the companies considered for this report.Biologics, Biosimilars,Pens, Pen Needles, Syringes,Type 1 Diabetes, Type 2 Diabetes

<b>Click to know more about product @ WMR</b>
<b><a href= “ Insulin Market by Drug type (Biolo”> Insulin Market by Drug type (Biolo</a></b>


For More info. Contact.
Scotie (Marketing & Sales)
Phone No (US). +1650-741-1345
Phone No (IN) +91 8766590136
Visit Our Website-
Connect with us – LinkedIn | Twitter| Facebook

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *